Arrowhead Pharmaceuticals, Inc.

Private Advisor Group, LLC ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

10,763

Value ($000)

715

Weight

0.0%

2020 Q2 - 2025 Q4 (19 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	715	0.0%	10,763	12/31/2025
2025 Q3	11/13/2025	371	0.0%	10,763	9/30/2025
2025 Q2	8/11/2025	178	0.0%	11,263	6/30/2025
2025 Q1	5/5/2025	143	0.0%	11,216	3/31/2025
2024 Q4	2/3/2025	211	0.0%	11,216	12/31/2024
2024 Q3	10/22/2024	220	0.0%	11,345	9/30/2024
2024 Q2	8/5/2024	296	0.0%	11,372	6/30/2024
2024 Q1	4/30/2024	325	0.0%	11,347	3/31/2024
2023 Q4	2/6/2024	362	0.0%	11,831	12/31/2023
2023 Q3	11/3/2023	317	0.0%	11,782	9/30/2023
2023 Q2	8/10/2023	420	0.0%	11,782	6/30/2023
2023 Q1	5/10/2023	300	0.0%	11,795	3/31/2023
2022 Q4	1/18/2023	0	0.0%	11,795	12/31/2022
2022 Q3	10/14/2022	390	0.0%	11,795	9/30/2022
2022 Q2	7/13/2022	404	0.0%	11,482	6/30/2022
2022 Q1	5/12/2022	531	0.0%	11,544	3/31/2022
2021 Q4	2/10/2022	766	0.0%	11,557	12/31/2021
2021 Q3	10/14/2021	714	0.0%	11,444	9/30/2021
2020 Q2	8/17/2020	10	0.0%	229	6/30/2020